Hanatani A, Shibata A, Kitada R, Iwata S, Matsumura Y, Doi A, Sugioka K, Takagi M, Yoshiyama M. Administration of tolvaptan with reduction of loop diuretics ameliorates congestion with improving renal dysfunction in patients with congestive heart failure and renal dysfunction. Heart Vessels. 2017 32:287-294.
Shibata A, Hanatani A, Izumi Y, Kitada R, Iwata S, Yoshiyama M.Serum brain-derived neurotrophic factor level and exercise tolerance complement each other in predicting the prognosis of patients with heart failure. Heart Vessels. 2018 Nov;33(11):1325-1333.
Norioka N, Iwata S, Ito A, Tamura S, Kawai Y, Nonin S, Ishikawa S, Doi A, Hanatani A, Yoshiyama M.Greater nighttime blood pressure variability is associated with left atrial enlargement in atrial fibrillation patients with preserved ejection fraction. Hypertens Res. 2018 Aug;41(8):614-621.
Nonin S, Iwata S, Ito A, Tamura S, Kitada R, Kawai Y, Ishikawa S, Doi A, Hanatani A, Yoshiyama M.Right ventricular enlargement predicts responsiveness to tolvaptan in congestive heart failure patients with reduced ejection fraction. Int J Cardiol Heart Vasc. 2018 Oct 10;21:69-73.